NO884788L - Nye rifamycin-derivater. - Google Patents

Nye rifamycin-derivater.

Info

Publication number
NO884788L
NO884788L NO88884788A NO884788A NO884788L NO 884788 L NO884788 L NO 884788L NO 88884788 A NO88884788 A NO 88884788A NO 884788 A NO884788 A NO 884788A NO 884788 L NO884788 L NO 884788L
Authority
NO
Norway
Prior art keywords
rifamycin derivatives
new rifamycin
new
derivatives
rifamycin
Prior art date
Application number
NO88884788A
Other languages
English (en)
Other versions
NO884788D0 (no
Inventor
Peter William Taylor
Ian Timothy William Matthews
Jane Isabelle Lowrie
Keith Allan Menear
Wilhelm Kump
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO884788D0 publication Critical patent/NO884788D0/no
Publication of NO884788L publication Critical patent/NO884788L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO88884788A 1987-10-27 1988-10-27 Nye rifamycin-derivater. NO884788L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878725118A GB8725118D0 (en) 1987-10-27 1987-10-27 Rifamycin derivatives

Publications (2)

Publication Number Publication Date
NO884788D0 NO884788D0 (no) 1988-10-27
NO884788L true NO884788L (no) 1989-04-28

Family

ID=10625948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884788A NO884788L (no) 1987-10-27 1988-10-27 Nye rifamycin-derivater.

Country Status (15)

Country Link
US (1) US5100894A (no)
EP (1) EP0314041A1 (no)
JP (1) JPH01149790A (no)
KR (1) KR890006651A (no)
AU (1) AU2434588A (no)
DD (2) DD283396A5 (no)
DK (1) DK594888A (no)
FI (1) FI884901A (no)
GB (1) GB8725118D0 (no)
HU (1) HU202871B (no)
IL (1) IL88113A0 (no)
NO (1) NO884788L (no)
NZ (1) NZ226704A (no)
PT (1) PT88848A (no)
ZA (2) ZA887965B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890701592A (ko) * 1987-10-27 1989-12-21 베르너 발데그 치환된 아자사이클로 헥실-유도체
US5180718A (en) * 1989-03-02 1993-01-19 Ciba-Geigy Corporation Acyl derivatives of oxazolorifamycins
CN106674225B (zh) * 2016-11-09 2019-04-02 珠海同源药业有限公司 一种核黄素磷酸钠化合物及其药物组合物
US20220289675A1 (en) * 2019-08-20 2022-09-15 Ono Pharmaceuticalco.,Ltd. Salt and crystal form of compound having agonistic activity to s1p5 receptor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE239795C (no) *
US4005077A (en) * 1965-08-24 1977-01-25 Ciba-Geigy Corporation Antibiotically active compounds
GB1486118A (en) * 1975-03-05 1977-09-21 Lepetit Spa Rifamycin derivatives
ATE47857T1 (de) * 1985-10-18 1989-11-15 Ciba Geigy Ag Substituierte 4-benzyl-piperazinyl-verbindungen.
US4876258A (en) * 1987-08-13 1989-10-24 Ciba-Geigy Corporation Biphenylyl compounds
JPH02501301A (ja) * 1987-09-25 1990-05-10 チバ‐ガイギー　アクチェンゲゼルシャフト ４‐（トリアルキルベンジル）‐ピペラジニル化合物のジアシル誘導体
US5003070A (en) * 1988-06-30 1991-03-26 Ciba-Geigy Corporation Substituted azacyclohexyl derivatives of rifamycins

Also Published As

Publication number Publication date
NO884788D0 (no) 1988-10-27
HU202871B (en) 1991-04-29
EP0314041A1 (en) 1989-05-03
DD283396A5 (de) 1990-10-10
PT88848A (pt) 1989-07-31
DK594888A (da) 1989-04-28
NZ226704A (en) 1991-04-26
GB8725118D0 (en) 1987-12-02
ZA887965B (en) 1989-06-28
KR890006651A (ko) 1989-06-15
FI884901A (fi) 1989-04-29
IL88113A0 (en) 1989-06-30
US5100894A (en) 1992-03-31
HUT50832A (en) 1990-03-28
DD290887A5 (de) 1991-06-13
AU2434588A (en) 1989-04-27
ZA887966B (en) 1989-06-28
FI884901A0 (fi) 1988-10-24
JPH01149790A (ja) 1989-06-12
DK594888D0 (da) 1988-10-26

Similar Documents

Publication Publication Date Title
DE122004000043I1 (de) Carbostryril-Derivate.
NO894919D0 (no) Nye aminobenzoater.
NO883226D0 (no) Nye aluminium-magnesium-hydroksy-forbindelser.
ATE74350T1 (de) Dehydrocholecalciferolderivate.
DE3872153D1 (de) 25-hydroxy-vitamin-d3-derivate.
FI882750A (fi) Tricykliska pyridonderivat.
ATE126800T1 (de) Neplanocinderivate.
FI883963A0 (fi) Isoxazol- -karbolinderivat.
DE68911192T2 (de) Phosphonoalkylpurin-Derivate.
DK453788A (da) Rifamycinderivater
DE58903265D1 (de) Fluorcyclopropyl-derivate.
NO894907L (no) Nye alfa-cyano-beta-oksopropionamider.
NO884788L (no) Nye rifamycin-derivater.
DE68913856D1 (de) Cycloalkylthiazol-Derivate.
DE3861208D1 (de) Hydroxyalkyl-triazolyl-derivate.
NO881899D0 (no) Nye 2-aminoalkyl-4-benzyl-1-(2h)-ftalazion-derivater.
NO892714D0 (no) Substituerte azacykloheksylderivater.
DE3866371D1 (de) Diphenylaethylen-derivate.
DE58900371D1 (de) 3-cyano-4-phenyl-pyrrol-derivate.
DE3868364D1 (de) Ucy-1003-derivate.
DE3863447D1 (de) Aminoethylphosphinsaeure-derivate.
DE3884482T2 (de) Thiapentanamid-Derivate.
DE3881146T2 (de) Thiazetidin-Derivate.
NO892643L (no) Substituerte azacykloheksyl-derivater.
FI880533A (fi) Tricykliska triazolopyrimidinderivat.